期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

海鞘类天然产物的临床研究进展 被引量：7

Advances in the study on clinical application of natural products from Ascidians
下载PDF
导出
摘要 综述目前已进入临床研究阶段的海鞘类天然化合物ET 74 3,DidemninB ,Aplidine的研究进展。 This article summarized the advances in the research of the natural products ET-743,Didemnin B and Aplidine,which were isolated from ascidians, and have been applied to clinical study at present.
作者 耿越 刘靓雯 张薛
机构地区 山东师范大学生命科学学院动物抗性生物学省重点实验室
出处 《中国海洋药物》 CAS CSCD 2004年第5期55-60,共6页 Chinese Journal of Marine Drugs
基金 山东省优秀中青年科学家奖励基金资助项目 (No.10 90 34)
关键词 临床研究进展 海鞘 ET-743 天然产物 综述 天然化合物 阶段 natural products ascidians clinical study
分类号 R730.269 [医药卫生—肿瘤] Q959 [生物学—动物学]
  • 相关文献

参考文献27

  • 1Verschraegen CF, Glover K. ET-743 (PharmaMar/NCI/Ortho Biotech) [J]. Curt Opin InvestinK DruKs, 2001, 2(11):1631.
  • 2Scotto KW. ET-743~ More than an innovative machanism of action[J]. Anticancer Drugs, 2002, 13 suppl 1 :S3.
  • 3Cvetkovic RS, Figgitt DP, Plosker GL. ET-743 [J].Drugs,2002,62(8) .- 1185.
  • 4Gajate CA. Mollinedo F. Differential cytostatic and apoptotic effects of ecteinascidin-743 in cancer cells. Transcriptiondependent cell cycle arrest and transcrlption-independent JNK and mitochondrial mediated apoptosis[J]. J Biol them, 2002,277(44) : 41580.
  • 5Michael V. Chemist Improves Synthesis of Scarce Drugs[R]. NIH Record, 2000.
  • 6Shengkan J, Barbara G, Glynn F, et al. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation[J]. Proc Natl Acad Sci USA, 2000,97 (12) :6775.
  • 7Kesteren C, Cvitkovic E, Taarnma A, eta1. Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinaseidin 743 in a phase I dose-finding study[J]. Clin Cancer Res, 2000,6(12) :4725.
  • 8Taamma A, Misset JL, Riofrio M, ee al. Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors[J]. J Clin Oncol, 2001,19(5) :1256.
  • 9Kesteren C, Twelves C, Bowman A, et al. Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study[J]. Anticuncer Drugs ,2002 , 13(4) : 381.
  • 10Villalona-Calero MA, Eckhardt SG, Weiss G, et al. A phase I and pharrnaeokinetie study of ecteinaseidin-743 on a daily x 5 schedule in patients with solid malignancies[J]. Clin Cancer Res ,2002,8(1) : 75.

同被引文献119

引证文献7

二级引证文献12

中国海洋药物
2004年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部